Medicine : Erlocip (100mg)

Name:Erlocip (100mg)
Manufacturer:Cipla Ltd
Generic Use:Erlotinib
Substitutes:tarceva (100mg) , erlocip (100mg)

Generic ( Erlotinib )

Typical use Of Erlotinib :Metastatic Lung Cancer, Metastatic Pancreatic Cancer.
Mechanism of action of Erlotinib :Erlotinib Inhibits The Intracellular Phosphorylation Of Tyrosine Kinase Associated With The Epidermal Growth Factor Receptor (EGFR). EGFR Is Expressed On The Cell Surface Of Normal Cells And Cancer Cells.
Drug Interaction of Erlotinib :Erlotinib Is Known To Interact With Other Drugs Like Atazanavir, Clarithromycin, Erythromycin, Indinavir (Sulphate), Itraconazole, Ketoconazole, Nefazodone (HCl), Nelfinavir, Rifabutin, Rifampicin, Ritonavir, Saquinavir, St.Johns Wort Extract, Telithromycin, Troleandomycin. Always Consult Your Physician For The Change Of Dose Regimen Or An Alternative Drug Of Choice That May Strictly Be Required.
Side effects of Erlotinib :Fatigue, Nausea, Vomiting, Anorexia, Diarrhea, Dyspnea, Abdominal Pain, Rashes, Stomatitis, Pruritus, Dyspepsia, Cough, Dry Skin, Conjunctivitis, Infection, Keratoconjunctivitis Sicca.


How Erlotinib will impact on Pregnancy ?

Experiences Of Drug Use And Evidence From Studies In Pregnant Women Have Shown Risk To Fetus. This Drug May Be Used In Pregnant Women If Benefit Outweighs The Risk. Patients Should Follow The Advice Of The Doctor Regarding Its Use.

How Erlotinib will impact during lactation(breastfeeding) ?

Contraindicated: The Drug Should Not Be Used By Breastfeeding Women, As Evidences From Studies Have Shown That There Is A High Risk Of Causing Significant Damage To Infants.

Medicine & Alcohol use and effect of Erlotinib

No Studies Found